Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 13/20 | 0.72 |
| ▸ | CA12 | O43570 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 1/20 | 0.64 |
| ▸ | CA9 | Q16790 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL635949 | 1.00 | ALDH1A1 (0.72) | ALDH1A1CA12CA2CA9HTT | |
| SCHEMBL28034898 | 1.00 | ALDH1A1 (0.72) | ALDH1A1CA12CA2CA9HTT | |
| SCHEMBL634180 | 1.00 | ALDH1A1 (0.72) | ALDH1A1CA12CA2CA9HTT | |
| SCHEMBL634183 | 1.00 | ALDH1A1 (0.72) | ALDH1A1CA12CA2CA9HTT | |
| SCHEMBL8355315 | 1.00 | ALDH1A1 (0.72) | ALDH1A1CA12CA2CA9HTT | |
| SCHEMBL5696735 | 1.00 | ALDH1A1 (0.72) | ALDH1A1CA12CA2CA9HTT | |
| SCHEMBL7103280 | 1.00 | ALDH1A1 (0.72) | ALDH1A1CA12CA2CA9HTT | |
| SCHEMBL223156 | 1.00 | ALDH1A1 (0.72) | ALDH1A1CA12CA2CA9HTT | |
| SCHEMBL635208 | 0.98 | ALDH1A1 (0.70) | ALDH1A1CA12CA2CA9HTT | |
| SCHEMBL187922 | 0.93 | ALDH1A1 (0.72) | ALDH1A1CA12CA2CA9HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559592-B2 | Branched amorphous polyamide (co)polymers and methods of making and using same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-02-24 | — | — | US | disclosed |
| CN-115003756-B | Resin composition | 松下知识产权经营株式会社 | 2024-10-01 | — | — | CN | disclosed |
| US-20230167243-A1 | BRANCHED AMORPHOUS POLYAMIDE (CO)POLYMERS AND METHODS OF MAKING AND USING SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2023-06-01 | — | — | US | disclosed |
| CN-115427532-A | Branched amorphous polyamide (co) polymers and methods of making and using the same | 3M创新有限公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-115003756-A | Resin composition | 松下知识产权经营株式会社 | 2022-09-02 | — | — | CN | disclosed |
| WO-2021152973-A1 | RESIN COMPOSITION | パナソニックＩＰマネジメント株式会社 | 2021-08-05 | — | — | WO | disclosed |
| EP-2302000-B1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORP (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-9051501-B2 | Curable composition and catalyst composition | KANEKA CORPORATION (JP) | 2015-06-09 | — | — | US | disclosed |
| EP-2100923-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2013-03-13 | — | — | EP | disclosed |
| EP-2088173-B1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORP (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-8008386-B2 | Curable composition | KANEKA CORPORATION (JP) | 2011-08-30 | — | — | US | disclosed |
| EP-2302000-A1 | Curable composition and catalyst composition | KANEKA CORPORATION (JP) | 2011-03-30 | — | — | EP | disclosed |
| US-20100063215-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2010-03-11 | — | — | US | disclosed |
| US-20100041810-A1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORPORATION (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2100923-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2009-09-16 | — | — | EP | disclosed |
| EP-2088173-A1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | Kaneka Corporation (JP) | 2009-08-12 | — | — | EP | disclosed |
| US-5922443-A | Polymeric article, such as a medical catheter, and method for making the same | BOSTON SCIENTIFIC GLENS FALLS CORP. | 1999-07-13 | — | — | US | disclosed |
| EP-0514913-B1 | A polymeric article, such as a medical catheter, and method for making the same | NAMIC CARIBE INC (PR) | 1997-03-12 | — | — | EP | disclosed |
| US-5484565-A | Method for making a medical catheter | NAMIC CARIBE, INC. (PR) | 1996-01-16 | — | — | US | disclosed |
| EP-0514913-A2 | A polymeric article, such as a medical catheter, and method for making the same | NAMIC CARIBE, INC. (PR) | 1992-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559592-B2 | Branched amorphous polyamide (co)polymers and methods of making and using same | COL2A1, PARG, COL1A1 | ALDH1A1 1929/4885CA12 2104/4885CA2 617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.